Assessment of Guideline-Nonconcordant Radiotherapy in Medicare Beneficiaries With Metastatic Cancer Near the End of Life, 2015-2017. - Santos PMG; Mathis NJ; Lapen K; Lobaugh S; Yerramilli D; Bekelman JE; Gillespie EF (JAMA health forum, 2022)